These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 9218525)
1. Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles. Castellani LW; Navab M; Van Lenten BJ; Hedrick CC; Hama SY; Goto AM; Fogelman AM; Lusis AJ J Clin Invest; 1997 Jul; 100(2):464-74. PubMed ID: 9218525 [TBL] [Abstract][Full Text] [Related]
2. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential. Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641 [TBL] [Abstract][Full Text] [Related]
3. Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII. Garner B; Waldeck AR; Witting PK; Rye KA; Stocker R J Biol Chem; 1998 Mar; 273(11):6088-95. PubMed ID: 9497326 [TBL] [Abstract][Full Text] [Related]
4. Enhanced cholesterol efflux by tyrosyl radical-oxidized high density lipoprotein is mediated by apolipoprotein AI-AII heterodimers. Wang WQ; Merriam DL; Moses AS; Francis GA J Biol Chem; 1998 Jul; 273(28):17391-8. PubMed ID: 9651324 [TBL] [Abstract][Full Text] [Related]
6. Role of the carboxy-terminal domain of human apolipoprotein AI in high-density-lipoprotein metabolism--a study based on deletion and substitution variants in transgenic mice. Holvoet P; Danloy S; Collen D Eur J Biochem; 1997 May; 245(3):642-7. PubMed ID: 9183000 [TBL] [Abstract][Full Text] [Related]
7. Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-beta particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transport. Castro G; Nihoul LP; Dengremont C; de Geitère C; Delfly B; Tailleux A; Fievet C; Duverger N; Denèfle P; Fruchart JC; Rubin EM Biochemistry; 1997 Feb; 36(8):2243-9. PubMed ID: 9047326 [TBL] [Abstract][Full Text] [Related]
8. Oxidation of high density lipoproteins. I. Formation of methionine sulfoxide in apolipoproteins AI and AII is an early event that accompanies lipid peroxidation and can be enhanced by alpha-tocopherol. Garner B; Witting PK; Waldeck AR; Christison JK; Raftery M; Stocker R J Biol Chem; 1998 Mar; 273(11):6080-7. PubMed ID: 9497325 [TBL] [Abstract][Full Text] [Related]
9. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis. Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499 [TBL] [Abstract][Full Text] [Related]
10. Influence of apolipoprotein composition of high density lipoprotein particles on cholesteryl ester transfer protein activity. Particles containing various proportions of apolipoproteins AI and AII. Lagrost L; Perségol L; Lallemant C; Gambert P J Biol Chem; 1994 Feb; 269(5):3189-97. PubMed ID: 8106353 [TBL] [Abstract][Full Text] [Related]
11. Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio. Navab M; Hama-Levy S; Van Lenten BJ; Fonarow GC; Cardinez CJ; Castellani LW; Brennan ML; Lusis AJ; Fogelman AM; La Du BN J Clin Invest; 1997 Apr; 99(8):2005-19. PubMed ID: 9109446 [TBL] [Abstract][Full Text] [Related]
12. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. Aviram M; Rosenblat M; Bisgaier CL; Newton RS; Primo-Parmo SL; La Du BN J Clin Invest; 1998 Apr; 101(8):1581-90. PubMed ID: 9541487 [TBL] [Abstract][Full Text] [Related]
13. Cholesterol mobilization by free and lipid-bound apoAI(Milano) and apoAI(Milano)-apoAII heterodimers. Wang WQ; Moses AS; Francis GA Biochemistry; 2001 Mar; 40(12):3666-73. PubMed ID: 11297434 [TBL] [Abstract][Full Text] [Related]
14. Determination of myeloperoxidase-induced apoAI-apoAII heterodimers in high-density lipoprotein. Kameda T; Usami Y; Shimada S; Haraguchi G; Matsuda K; Sugano M; Kurihara Y; Isobe M; Tozuka M Ann Clin Lab Sci; 2012; 42(4):384-91. PubMed ID: 23090734 [TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. Van Lenten BJ; Hama SY; de Beer FC; Stafforini DM; McIntyre TM; Prescott SM; La Du BN; Fogelman AM; Navab M J Clin Invest; 1995 Dec; 96(6):2758-67. PubMed ID: 8675645 [TBL] [Abstract][Full Text] [Related]
16. Lack of protection against oxidative modification of LDL by avian HDL. Mackness B; Durrington PN; Mackness MI Biochem Biophys Res Commun; 1998 Jun; 247(2):443-6. PubMed ID: 9642147 [TBL] [Abstract][Full Text] [Related]
17. Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model. Shih DM; Gu L; Hama S; Xia YR; Navab M; Fogelman AM; Lusis AJ J Clin Invest; 1996 Apr; 97(7):1630-9. PubMed ID: 8601628 [TBL] [Abstract][Full Text] [Related]
18. Increased cholesterol efflux in apolipoprotein AI (ApoAI)-producing macrophages as a mechanism for reduced atherosclerosis in ApoAI((-/-)) mice. Major AS; Dove DE; Ishiguro H; Su YR; Brown AM; Liu L; Carter KJ; Linton MF; Fazio S Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1790-5. PubMed ID: 11701467 [TBL] [Abstract][Full Text] [Related]
19. In vivo interactions of apoA-II, apoA-I, and hepatic lipase contributing to HDL structure and antiatherogenic functions. Hedrick CC; Castellani LW; Wong H; Lusis AJ J Lipid Res; 2001 Apr; 42(4):563-70. PubMed ID: 11290828 [TBL] [Abstract][Full Text] [Related]
20. Changed affinity of apolipoprotein AII to high density lipoprotein (HDL) in patients with familial amyloidotic polyneuropathy (FAP) type I. Tanaka Y; Ando Y; Kumamoto T; Miyazaki A; Nakamura M; Nakayama M; Araki S; Ando M Biochim Biophys Acta; 1994 Feb; 1225(3):311-6. PubMed ID: 8312379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]